Elecsys technology
ECL (ElectroChemiLuminescence) is Roche’s technology for immunoassay detection. Based on this technology and combined
with well‑designed, specific and sensitive immunoassays, Elecsys delivers reliable results. The development of ECL immunoas‑
says is based on the use of a ruthenium‑complex and tripropylamine (TPA). The chemiluminescence reaction for the detection
of the reaction complex is initiated by applying a voltage to the sample solution resulting in a precisely controlled reaction.
ECL technology can accommodate many immunoassay principles while providing superior performance